Navigation Links
Progression of retinal disease linked to cell starvation
Date:12/7/2008

BOSTON, Mass. (Dec. 7, 2008) Rods and cones coexist peacefully in healthy retinas. Both types of cells occupy the same layer of tissue and send signals when they detect light, which is the first step in vision. The incurable eye disease Retinitis Pigmentosa, however, reveals a codependent relationship between the two that can be destructive. When flawed rods begin to die, otherwise normal cones follow them to the grave, leading to blindness. A new study might explain why.

Data published online in Nature Neuroscience Dec. 7 suggest the cones are starving to death. As rods disappear, the structure of the retina breaks down. This might disrupt the connections between the cones and their source of nutrients.

"This is the first study linking cone death in Retinitis Pigmentosa to a metabolic problem that suggests starvation," says senior author Constance Cepko, an HMS professor and investigator with Howard Hughes Medical Institute. "If we can find a way to supply nutrients to the cones, we might be able to preserve daylight vision in patients."

Active in bright light, cones allow us to perceive color and fine details. Conversely, rods allow us to see in dim light. The untrained eye cannot distinguish between the two types of cells, which grow side-by-side. Both rods and cones have a protrusion that has many membranous discs, resembling a stack of cookies. A cone stack is half the height of a rod stack. Stacks emanating from both types of cells get clustered together, like Oreos on a plate. The entire plate gets covered in "plastic," with the flexible plastic reaching down to touch each stack. In the eye, this plastic consists of a giant retinal pigment (RPE) cell, which supplies nutrients to the rods and cones on its plate.

With this structure in mind, researchers have proposed a variety of hypotheses to explain the loss of cones in patients with mutations in rod-specific genes. For example, some teams have suggested that rods produce a chemical cones need to survive. But the data didn't quite fit the proposed models.

Cekpo's team took a fresh approach to the problem. Postdoctoral researcher Claudio Punzo gathered four strains of mice, each with a different rod-specific mutation and a different rate of disease progression. He discovered an interesting pattern. Cone death always began after the major phase of rod death.

Punzo analyzed gene expression before and after this point in each strain. During the cone death phase, 230 genes were always expressed at higher levels. Sleuthing revealed that 34.9 percent of those play a role in cellular metabolism, including 12 genes in the insulin/mTOR pathway.

mTOR serves as a signaling hub, gathering information about the environment and helping the cell to decide whether it has enough nutrients to make new proteins. Punzo now had a lead. Further experiments suggested the cones weren't getting enough glucose. Not only did they express high levels of a protein that allows the cell to take up more glucose, but the cones survived longer when Punzo tricked them into thinking they had enough glucose by injecting the mice with insulin.

"Apparently, the cones caught onto our trick," says Punzo. "After surviving longer than usual, they started to die in droves."

Cepko and Punzo say the new hypothesis makes sense. Rods outnumber cones by more than 20 to 1. The RPE cells sag when too many rods disappear, as the plastic over that plate of Oreo cookies droops when too many stacks are missing. The structural change likely disturbs the contacts between RPE cells and cones, impeding the flow of nutrients to the cones.

"This points us in a new direction," says Cepko. "We're currently exploring ways to boost nutrient levels in the cones. Perhaps someday we can help Retinitis Pigmentosa patients maintain their daylight vision for at least a bit longer than they otherwise would."


'/>"/>

Contact: Alyssa Kneller
alyssa_kneller@hms.harvard.edu
617-432-0442
Harvard Medical School
Source:Eurekalert

Related biology news :

1. Height linked to risk of prostate cancer development and progression
2. Genetics of ALS progression
3. Gene therapy slows progression of fatal neurodegenerative disease in children
4. Study shows link between alcohol consumption and hiv disease progression
5. Study begins to reveal clues to the cause and progression of sepsis
6. Gene therapy restores vision to mice with retinal degeneration
7. St. Jude defines eye cancer genes role in retinal development
8. Twinkle after-effect can help retinal patients detect vision loss quickly and cheaply
9. Scientists eye secrets of retinal regeneration
10. Maintaining the brains wiring in aging and disease
11. Red alert! How disease disables tomato plants intruder alarm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... June 2, 2016 The Department of ... awarded the 44 million US Dollar project, for the ... Plates including Personalization, Enrolment, and IT Infrastructure , ... the production and implementation of Identity Management Solutions. Numerous renowned ... Decatur was selected for the most ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
(Date:4/28/2016)... and BANGALORE, India , April ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... today announced a global partnership that will provide ... to use mobile banking and payment services.      ... a key innovation area for financial services, but it also ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology: